The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results